Clinical trial
Combination Chemotherapy Plus Radiation Therapy in Treating Patients With…
NCT00005638 · Memorial Sloan Kettering Cancer Center, Other · Completed
Key facts
| NCT number | NCT00005638 |
|---|---|
| Title | Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Esophageal Cancer |
| Official title | Phase I Trial of Combined Modality Irinotecan, Cisplatin, and Concurrent Radiation Therapy for Patients With Locally Advanced Esophageal Cancer |
| Lead sponsor | Memorial Sloan Kettering Cancer Center, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Esophageal Cancer, Gastric Cancer |
| Intervention type | Drug, Radiation |
| Interventions | cisplatin, irinotecan hydrochloride, radiation therapy |
| Start date | Oct 1, 1999 |
| Primary completion | Apr 1, 2004 |
| Completion | Apr 1, 2004 |
| First posted | Jan 27, 2003 |
| Last update posted | Jun 19, 2013 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: